ibreakstock/iStock via Getty Images Biodexa (NASDAQ:BDRX) stock shot up 70% in morning trading Thursday after the company re-released positive data from a Phase 2 study for its drug eRapa in the treatment of Familial Adenomatous Polyposis, for FAP. According to the company’s release Thursday, 12-month data from the Phase 2Continue Reading
Paris, France, July 10th, 2024, Chainwire The pioneering company behind Usual, Usual Labs, an innovative protocol bridging traditional and decentralized finance (DeFi) through its first USD0 stablecoin, is thrilled to announce the commencement of its public pre-launch phase. This milestone follows a fruitful private launch, during which Usual Labs securedContinue Reading
Johnce/E+ via Getty Images Fluor Corp (NYSE:FLR) has been awarded an engineering, procurement and construction management services contract for phase one of Northvolt’s large-scale lithium-ion battery factory in Heide, Germany, it said Thursday. Fluor (FLR) will recognize its undisclosed portion of the total $4.8 billion (€4.5 billion) project in theContinue Reading
JHVEPhoto/iStock Editorial via Getty Images Novo Nordisk (NVO) said that ocedurenone, under investigation for uncontrolled hypertension in chronic kidney disease patients, missed its primary endpoint in a phase 3 trial. That endpoint was change in systolic blood pressure from baseline to week 12. As a result, the Danish pharma isContinue Reading
